Literature DB >> 8985073

Studies on the duration of antibiotic administration for surgical prophylaxis.

K S Scher1.   

Abstract

Patients undergoing 801 elective, clean-contaminated operations were assigned to one of the three following antibiotic regimens: 1) 1 g of cefazolin preoperatively, 2) 1 g of cefazolin preoperatively and another 1-g dose 3 hours later, and 3) 1 g of cefotetan preoperatively. These antibiotic regimens resulted in similar wound infection rates for procedures completed within 3 hours. When the procedure lasted more than 3 hours, the 6.1 per cent infection rate noted when a single dose of cefazolin was given proved significantly greater than the 1.3 per cent infection rates associated with the use of two doses of cefazolin or a single dose of the longer acting antibiotic, cefotetan (P < 0.01). Another series of 768 patients undergoing biliary and gastrointestinal tract operations were assigned to one of two antibiotic regimens: 1) a preoperative dose of 1 g of cefazolin and another 1-g dose 3 hours later if still in the operating room; 2) same as (1), plus 1-g doses every 8 hours for 24 hours. The longer period of antibiotic administration failed to improve the wound infection rate compared to the use of perioperative coverage only. These studies suggest that a single dose of preoperative antibiotic is sufficient for surgical prophylaxis when the operation is completed within 3 hours. Antibiotic coverage must extend for the duration of longer operations. A second dose of antibiotic or a single preoperative dose of an extended half-life antibiotic are equally effective. There is no value to administering antibiotics after the operation has been completed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985073

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  16 in total

1.  Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients.

Authors:  R Tang; H H Chen; Y L Wang; C R Changchien; J S Chen; K C Hsu; J M Chiang; J Y Wang
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

2.  Survey of surgical antimicrobial prophylaxis in czech republic.

Authors:  Retnosari Andrajati; Jiri Vlcek; Milan Kolar; Ráchel Pípalová
Journal:  Pharm World Sci       Date:  2005-12

3.  Antimicrobial Prophylaxis Redosing Reduces Surgical Site Infection Risk in Prolonged Duration Surgery Irrespective of Its Timing.

Authors:  Daniela Bertschi; Walter P Weber; Jasmin Zeindler; Daniel Stekhoven; Robert Mechera; Lilian Salm; Marco Kralijevic; Savas D Soysal; Marco von Strauss; Edin Mujagic; Walter R Marti
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

Review 4.  Prophylactic antibiotics in pediatric neurological surgery.

Authors:  Friederike Knerlich-Lukoschus; Martina Messing-Jünger
Journal:  Childs Nerv Syst       Date:  2018-06-16       Impact factor: 1.475

Review 5.  Antibiotic prophylaxis in craniotomy: a review.

Authors:  Weiming Liu; Ming Ni; Yuewei Zhang; Rob J M Groen
Journal:  Neurosurg Rev       Date:  2014-02-13       Impact factor: 3.042

6.  The significance of the intraoperative repeated dosing of antimicrobials for preventing surgical wound infection in colorectal surgery.

Authors:  Shunji Morita; Isamu Nishisho; Takashi Nomura; Yukio Fukushima; Takashi Morimoto; Nobuaki Hiraoka; Nobuhiro Shibata
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

7.  Update on the Epidemiology and Prevention of Surgical Site Infections.

Authors:  Tae Chong; Robert Sawyer
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

8.  Assessment of prophylactic antibiotic use in patients with surgical site infections.

Authors:  Whitney J Goede; Jenna K Lovely; Rodney L Thompson; Robert R Cima
Journal:  Hosp Pharm       Date:  2013-07

9.  Prior inpatient admission increases the risk of post-operative infection in hepatobiliary and pancreatic surgery.

Authors:  Zachary M Dong; Alexis P Chidi; Julie Goswami; Katrina Han; Richard L Simmons; Matthew R Rosengart; Allan Tsung
Journal:  HPB (Oxford)       Date:  2015-09-03       Impact factor: 3.647

10.  RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus.

Authors:  Andrea Giacometti; Oscar Cirioni; Yael Gov; Roberto Ghiselli; Maria Simona Del Prete; Federico Mocchegiani; Vittorio Saba; Fiorenza Orlando; Giorgio Scalise; Naomi Balaban; Giorgio Dell'Acqua
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.